The primary mission of the Human Tissue Acquisition and Pathology Shared Resource (HTAP) is to provide Vanderbilt Cancer Center investigators with access to human tissue for the purpose of carrying out translational research. There are two main components to this Shared Resource: 1) human tissue procurement, and 2) research histology. Each of these components provides critical reagents that allow basic and applied scientific investigations of human tissues with appropriate attention to ethical concerns. Our mission is facilitated by our highly experienced personnel and a close working relationship with the Anatomic Pathology Division of the Department of Pathology. Dr. Jensen has an NCI-funded program of investigation and is an attending physician in Pathology. Ms. Newsom-Johnson worked in the Department of Pathology for over 15 years. Therefore the personnel that staff the Shared Resource have a keen appreciation of the needs of cancer researchers and are very knowledgeable concerning the need for appropriate evaluation of clinical specimens. The HTAP Shared Resource has experienced substantial growth over the last three years and has served 42 different investigators 23 of whom are Cancer Center members. During this period we have provided approximately 24,000 slides, 3,000 blocks, and provided 2,000 frozen specimens to the Vanderbilt research community. We expect continued growth for the next several years and we are in the process of adding additional personnel to keep up with the increased demand for our services. Also, due to the expressed interests from a number of Cancer Center investigators we are adding a microdissection service to the Shared Resource that will enable investigators to carefully separate tumor and normal cells for genetic and biochemical analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-04
Application #
6232783
Study Section
Subcommittee G - Education (NCI)
Project Start
1995-09-05
Project End
2004-08-31
Budget Start
Budget End
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Yang, Yaohua; Cai, Qiuyin; Shu, Xiao-Ou et al. (2018) Prospective study of oral microbiome and colorectal cancer risk in low-income and African American populations. Int J Cancer :

Showing the most recent 10 out of 2462 publications